| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 04/04/1996 | CA2199044A1 Novel estrenes for inducing hypothalamic effects |
| 04/04/1996 | CA2199043A1 Novel androstanes for inducing hypothalamic effects |
| 04/02/1996 | US5504074 Administering substituted estranes to suppress vascularization |
| 03/26/1996 | US5502183 Steroid intermediates and processes for their preparation |
| 03/26/1996 | US5502044 Fluorinated 4-aminoandrostadienone derivatives and process for their preparation |
| 03/26/1996 | CA1338187C Halogen labeled compounds including estradiol derivatives, synthetic intermediates, syntheses thereof and uses thereof |
| 03/21/1996 | DE4439488C1 Verfahren zur Umwandlung von Hydroxylgruppen in die entsprechenden Fluorverbindungen A process for converting hydroxyl groups into the corresponding fluoro compounds |
| 03/20/1996 | EP0417281B1 COMPOSITION CONTAINING 5$g(a)-DIHYDRO-19-NORETHYSTERONE AND ITS DERIVATIVES CAPABLE OF INHIBITING AROMATASE IN VIVO |
| 03/13/1996 | EP0700926A1 Process for the preparation of gestodene |
| 03/13/1996 | EP0700293A1 Dihydrotestosterone for use in androgenotherapy |
| 03/13/1996 | EP0700291A1 15-substituted 4-azasteroids |
| 03/13/1996 | EP0495825B1 Use of antigestagens in the manufacture of medicaments |
| 03/12/1996 | USRE35177 N-fluoropyridinium salt and process for preparing same |
| 03/10/1996 | CA2157076A1 Process for the preparation of gestodene |
| 03/05/1996 | US5496814 Steroids for bone disorders and oxidation resistance |
| 03/05/1996 | US5496556 Administering a steroid reductase inhibiting compound, an androstene derivative |
| 02/28/1996 | CN1117735A Steroids for treating menopausal complaints |
| 02/27/1996 | US5494914 Useful for treatment of diseases whose progress is aided by activation of androgen receptors |
| 02/27/1996 | US5494907 11-β substituted-19-nor steroids |
| 02/22/1996 | WO1996005216A1 Estra-1,3,5(10)-triene derivatives, methods of preparing such compounds and pharmaceutical compositions containing them |
| 02/22/1996 | WO1996004917A1 Remedy for myotonic dystrophy |
| 02/22/1996 | WO1996004912A1 Use of ketoconazole and related substances in medicaments for treatment of type ii diabetes |
| 02/22/1996 | CA2196694A1 Estra-1,3,5(10)-triene derivatives, process of preparing such compounds and pharmaceutical compositions containing them |
| 02/21/1996 | CN1117050A 14 alpha, 17 alpha-ethano-16 alpha-hydroxy-estratriene |
| 02/21/1996 | CN1031061C Process for preparing of 14 alpha, 17 alpha-ethano-16 alph-hydroxy-estratriene derivatives |
| 02/21/1996 | CN1031060C Process for preparing esters |
| 02/15/1996 | DE4429397A1 Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen Estra-1,3,5 (10) -triene derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 02/14/1996 | EP0696454A2 Pharmaceutical preparation for contraception/hormonsubstitution with biogenic estrogen components |
| 02/14/1996 | CN1116823A Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 02/13/1996 | US5491138 Estradiol derivative alkylating agent conjugate with reduced hormonal activity, process for preparing the same, compounds useful for the preparation thereof, and growth inhibiting composition containing the conjugate or estradiol derivative |
| 02/13/1996 | US5491071 Labels; test kits; immunoassays |
| 02/08/1996 | WO1996003419A1 Tetracyclic triterpenes |
| 02/08/1996 | CA2192789A1 Tetracyclic triterpenes |
| 02/07/1996 | CN1116208A 9-alpha-hydroxy steroids, process for their preparation, process for the preparation of the corresponding 9(11)-dehydro derivatives and pharmaceutical preparations containing said steroids |
| 02/06/1996 | US5489581 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 01/31/1996 | EP0694038A1 Novel androgens and anabolic agents |
| 01/24/1996 | EP0692980A1 Type s3n2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical use |
| 01/24/1996 | EP0692979A1 Bifunctional chelators and their use in radiopharmaceuticals |
| 01/24/1996 | EP0692976A1 Chelating agents of the type xn 1?s 1?o 1? for radioactive isotopes, metal complexes thereof, and their use in diagnosis and therapy |
| 01/17/1996 | EP0691974A1 Alkylating agent and 1,4-addition process of an alkyl group onto an alpha, beta-unsaturated ketone compound |
| 01/17/1996 | EP0552202B1 Methods mediated by the proto-oncogenic protein complex AP-1 |
| 01/02/1996 | US5480913 Anti-androgen compounds |
| 01/02/1996 | US5480878 Method for treating prostatic hypertrophy with estradiol derivatives |
| 12/27/1995 | EP0688785A2 Manufacture of catechol estrogens derivatives |
| 12/27/1995 | EP0688565A1 Tablet, capsule, or granule comprising desogestrel |
| 12/27/1995 | EP0688220A1 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 12/26/1995 | US5478957 Preparation of 6α, 9α-difluoro steroids |
| 12/26/1995 | US5478862 Having progestational activity with minimum ancillary hormonal activity; antiovulation agents |
| 12/26/1995 | US5478818 Estradiol derivative-alkylating agent conjugate with reduced hormonal activity, process for preparing the same, compounds useful for the preparation thereof, and growth inhibiting composition containing the conjugate or estradiol derivative |
| 12/13/1995 | EP0686613A1 Ozonide reducing agent |
| 12/06/1995 | EP0684825A1 Method of preventing or inhibiting fertilization |
| 11/22/1995 | EP0682672A1 Steroids for treating menopausal complaints |
| 11/16/1995 | WO1995030684A1 SYNTHESIS OF 17β-CYANO-3-ETHOXY-17α-HYDROXY-6-METHYLANDROSTA-3,5,9(11)-TRIENE |
| 11/16/1995 | CA2187522A1 Synthesis of 17.beta.-cyano-3-ethoxy-17.alpha.-hydroxy-6-methylandrosta-3,5,9(11)-triene |
| 11/15/1995 | EP0650521A4 Determination of estradiol by competitive immunoassay. |
| 11/08/1995 | EP0680327A1 Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 10/26/1995 | WO1995028413A1 17β-SUBSTITUTED 3-CARBOXY STEROIDS THAT INHIBIT 5-α-REDUCTASE |
| 10/25/1995 | EP0678027A1 Anti-atherosclerotic agents |
| 10/19/1995 | WO1995027724A1 An equilin double bond isomer from the acid isomerization of equilin |
| 10/19/1995 | WO1995027702A1 Novel functionalized hydrophilic acridinium esters |
| 10/19/1995 | WO1995027701A1 Metal-containing steroid mimics and ligands useful in the preparation thereof |
| 10/19/1995 | CA2186486A1 An equilin double bond isomer from the acid isomerization of equilin |
| 10/19/1995 | CA2186463A1 Novel functionalized hydrophilic acridinium esters |
| 10/18/1995 | EP0500899B1 Novel 15,16-seco-19-nor progestins |
| 10/18/1995 | CN1030081C New 11-aryl sleroid derivs |
| 10/12/1995 | WO1995026731A1 Treating cardiovascular disease with steroidal 5-alpha-reductase inhibitors |
| 10/12/1995 | WO1995026730A1 Combined hormonal contraception pharmaceutical preparation |
| 10/12/1995 | CA2186739A1 Combined hormonal contraception pharmaceutical preparation |
| 10/11/1995 | CN1029975C Process for preparing 9(11)-dehydro steroids |
| 10/05/1995 | WO1995026200A1 Enhanced virus-mediated dna transfer |
| 10/05/1995 | DE4411585A1 Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption A pharmaceutical combination hormonal contraception |
| 09/27/1995 | EP0673251A1 17 substituted acyl-3-carboxy 3,5-diene steroidals as 5-alpha-reductase inhibitors |
| 09/27/1995 | EP0462189B1 Combination therapy for treatment of estrogen sensitive diseases |
| 09/20/1995 | EP0614356B1 Transdermal estradiol delivery system |
| 09/20/1995 | EP0445244B1 Process for preparing 3-hydroxy-1,3,5(10)-estratriene-17-one |
| 09/12/1995 | US5449556 Chemiluminescent markers |
| 09/06/1995 | EP0669932A1 17-alpha and 17-beta substituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-alpha-reductase |
| 09/06/1995 | CN1029683C Process for preparing new steroids substituted at position 10 by a radical including a double or triple bond |
| 08/31/1995 | WO1995018821A3 Novel antiandrogenic agents and related pharmaceutical compositions and methods of use |
| 08/30/1995 | CN1107478A Steroalkenol polyfluohydrocarbyl sulfonate compound and its deriv., use and preparing process |
| 08/29/1995 | US5446036 13-alkyl-11beta-phenylgonanes |
| 08/23/1995 | EP0510167B1 Novel steroidal organic substance crystallization method and compounds thereby obtained |
| 08/22/1995 | US5443837 Parenterally administering 17-alpha-allyl-4,9,11-estratriene-17beta-ol-3-one to breeding animals |
| 08/17/1995 | WO1995019186A3 Contrast media for x-ray and magnetic resonance imaging |
| 08/16/1995 | EP0666746A1 $g(D)5-ANDROSTENES USEFUL FOR PROMOTING WEIGHT MAINTENANCE OR WEIGHT LOSS AND TREATMENT PROCESS |
| 08/09/1995 | EP0665849A1 Method of alkylating oestrone derivatives. |
| 08/09/1995 | EP0665752A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof |
| 08/03/1995 | WO1995020567A1 Codrugs as a method of controlled drug delivery |
| 08/01/1995 | US5438134 Process for the production of unsaturated 17 α-cyanomethyl-17 β-h |
| 08/01/1995 | US5438061 7-substituted-δ4-6-azasteroid derivatives as 5α-reductase inhibitors |
| 07/26/1995 | CN1105669A Compound used as bone targetted drug with estrin structure |
| 07/20/1995 | WO1995019186A2 Contrast media for x-ray and magnetic resonance imaging |
| 07/13/1995 | WO1995018821A2 Novel antiandrogenic agents and related pharmaceutical compositions and methods of use |
| 07/13/1995 | WO1995018621A1 Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids |
| 07/13/1995 | CA2180548A1 Novel antiandrogenic agents and related pharmaceutical compositions and methods of use |
| 07/06/1995 | WO1995018082A1 Ozonide reducing agent |
| 06/21/1995 | EP0658533A1 Process for the oxidation of primary and secondary alcohols to aldehydes and ketones and for the oxidation of 1,2-diols to alpha-ketols and alpha-diketones |
| 06/20/1995 | US5426198 Contacting steroid in solution with chromium ion, hydrogen radical source, reducing agent |
| 06/20/1995 | US5426102 Antigestagenic, antiandrogenic, antiglucocorticoid, antimineralcorticoid properties |
| 06/14/1995 | EP0656901A1 Fluorinated 6-methylenandrosta-1,4-dien-3-one derivatives and process for their preparation |